2013
Transforming growth factor-β1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation
Tal R, Seifer DB, Shohat-Tal A, Grazi RV, Malter HE. Transforming growth factor-β1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation. Fertility And Sterility 2013, 100: 538-543. PMID: 23684116, DOI: 10.1016/j.fertnstert.2013.04.022.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntigens, CDCase-Control StudiesEndoglinFemaleFertilization in VitroFollicular FluidHumansInfertility, FemaleOvarian Hyperstimulation SyndromeOvulation InductionPolycystic Ovary SyndromeReceptors, Cell SurfaceSperm Injections, IntracytoplasmicTransforming Growth Factor beta1UltrasonographyYoung AdultConceptsPolycystic ovarian syndromeSerum soluble endoglinDay of hCGSoluble endoglinFollicular fluidTGF-β1Oocyte retrievalOvarian stimulationHCG administrationControl womenDay 3Pathogenesis of PCOSNon-PCOS control groupProspective case-control studyNon-PCOS controlsSerum TGF-β1Non-PCOS womenPolycystic ovary syndromeTGF-β1 levelsReproductive technology unitCase-control studyGrowth factor-β1Day of retrievalOvarian hyperstimulationOvarian syndrome
2012
The Role of Hypoxia and Hypoxia-Inducible Factor-1Alpha in Preeclampsia Pathogenesis
Tal R. The Role of Hypoxia and Hypoxia-Inducible Factor-1Alpha in Preeclampsia Pathogenesis. Biology Of Reproduction 2012, 87: 134, 1-8. PMID: 23034156, DOI: 10.1095/biolreprod.112.102723.Peer-Reviewed Original ResearchConceptsSoluble fms-like tyrosine kinase-1Pathogenesis of preeclampsiaRole of hypoxiaSoluble endoglinAngiotensin II receptor type IFms-like tyrosine kinase-1Spiral artery remodelingTyrosine kinase-1Hypoxia-inducible factor-1alphaReceptor type IHypoxia-inducible factorMaternal manifestationsPutative culpritsFetal morbiditySymptomatic therapyArtery remodelingPlacental hypoxiaCascade of eventsEndothelin-1Preeclampsia pathogenesisDisease manifestationsPossible molecular linkPreeclampsiaEffective preventionPathogenesisPreeclampsia-associated soluble endoglin (sENG) is decreased in polycystic ovarian syndrome (PCOS) leading to transforming growth factor (TGF)-B1 dysregulation during controlled ovarian stimulation
Tal R, Seifer D, Shohat-Tal A, Grazi R, Malter H. Preeclampsia-associated soluble endoglin (sENG) is decreased in polycystic ovarian syndrome (PCOS) leading to transforming growth factor (TGF)-B1 dysregulation during controlled ovarian stimulation. Fertility And Sterility 2012, 98: s84. DOI: 10.1016/j.fertnstert.2012.07.304.Peer-Reviewed Original Research
2010
Effects of Hypoxia-Inducible Factor-1α Overexpression in Pregnant Mice Possible Implications for Preeclampsia and Intrauterine Growth Restriction
Tal R, Shaish A, Barshack I, Polak-Charcon S, Afek A, Volkov A, Feldman B, Avivi C, Harats D. Effects of Hypoxia-Inducible Factor-1α Overexpression in Pregnant Mice Possible Implications for Preeclampsia and Intrauterine Growth Restriction. American Journal Of Pathology 2010, 177: 2950-2962. PMID: 20952590, PMCID: PMC2993274, DOI: 10.2353/ajpath.2010.090800.Peer-Reviewed Original ResearchConceptsIntrauterine growth restrictionHIF-1αControl micePregnant miceGrowth restrictionFetal intrauterine growth restrictionSoluble vascular endothelial growth factor receptor-1Vascular endothelial growth factor receptor 1Serum sFlt-1Elevated liver enzymesLiver enzyme levelsMicroangiopathic hemolytic anemiaPregnancy-specific disorderHypoxia-inducible factor-1αComplete blood countGestational day 8Growth factor receptor 1HIF-1α overexpressionFactor receptor 1Hypoxia-inducible factorPlacental weightPregnant controlsSoluble endoglinBlood pressureSignificant anemia